Beam Therapeutics
BEAM
24.77
-0.46
-1.82%
Beam Therapeutics
US · BEAM
#2614 by market cap
Listed 2020
24.77
-0.46
-1.82%
Live - 5344 symbols - heartbeat 402s ago
· 2026-10-08 09:09
Pre-market
24.21
-2.26%
After-hours
25.00
+0.91%
Overnight
24.72
-0.20%
- Market cap
- 2.56B
- P/E (TTM)i
- -35.90
- P/Bi
- 2.40
- EPSi
- -0.81
- Div yieldi
- 0.00%
- 52W posi
- 25%
Reader sentiment
Are you bullish or bearish on BEAM?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
53.38 +115.5%
Price target rangecurrent 24.77
Low35.00
Avg53.38
High80.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-09 | CCORF | -- | BUY | 78.00 |
| 2026-09-09 | JonesTrading | -- | BUY | 35.00 |
| 2026-09-09 | Wedbush | -- | BUY | 65.00 |
| 2026-09-09 | Clear Street | -- | BUY | 37.00 |
| 2026-09-09 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-09-08 | William Blair | -- | BUY | -- |
| 2026-09-08 | BofA Securities | -- | BUY | 43.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-08-25 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-08-06 | J.P. Morgan | -- | BUY | 44.00 |
| 2026-08-05 | CCORF | -- | BUY | 78.00 |
| 2026-08-05 | BofA Securities | -- | BUY | 43.00 |
| 2026-08-05 | Evercore | -- | BUY | 45.00 |
| 2026-08-04 | William Blair | -- | BUY | -- |
| 2026-08-04 | JonesTrading | -- | BUY | 35.00 |
| 2026-07-08 | BofA Securities | -- | BUY | 47.00 |
| 2026-07-07 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-05-21 | CCORF | -- | BUY | 75.00 |
| 2026-05-21 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-05-14 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-05-13 | Citi | -- | BUY | 68.00 |
| 2026-05-13 | H.C. Wainwright | -- | BUY | 80.00 |
| 2026-05-12 | BofA Securities | -- | BUY | 47.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2025/Q4 | 2026-02-24 | -- | ±20.90% | +13.98% (in line) |
| 2024/Q3 | 2024-11-05 | -- | -- | -1.77% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 09:09:42 · For reference only, not investment advice and not tailored to your situation.